Join
Live feed
·
INSIDERFilingvia Quantisnow
Brainstorm Cell Therapeutics Inc. logo

President & CEO Lebovits Chaim bought $11,308 worth of shares (23,836 units at $0.47), decreasing direct ownership by 93% to 80,960 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BCLI· Brainstorm Cell Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCLI (Brainstorm Cell Therapeutics Inc.) and more on Quantisnow.